Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy

Yeying Wang,1,2 Li Ai,1 Jiahong Luo,2 Ran Li,1 Yanlin Chai,1 Xiaojie He,1 Yu Cao,1 Yongxia Li1 1Department of Respiratory Medicine, The Second Affiliated Hospital of Kunming Medical University, 2Department of Epidemiology and Biostatistics, School of Public Health, Kunming Medical University, Cheng...

Full description

Bibliographic Details
Main Authors: Wang Y, Ai L, Luo J, Li R, Chai Y, He X, Cao Y, Li Y
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/effect-of--adherence-on-daytime-sleepiness-fatigue-depression-and-slee-peer-reviewed-article-PPA
_version_ 1811254505527836672
author Wang Y
Ai L
Luo J
Li R
Chai Y
He X
Cao Y
Li Y
author_facet Wang Y
Ai L
Luo J
Li R
Chai Y
He X
Cao Y
Li Y
author_sort Wang Y
collection DOAJ
description Yeying Wang,1,2 Li Ai,1 Jiahong Luo,2 Ran Li,1 Yanlin Chai,1 Xiaojie He,1 Yu Cao,1 Yongxia Li1 1Department of Respiratory Medicine, The Second Affiliated Hospital of Kunming Medical University, 2Department of Epidemiology and Biostatistics, School of Public Health, Kunming Medical University, Chenggong New City, Kunming, Yunnan Province, People’s Republic of China Objectives: The aims of this study were to describe changes in day- and nighttime symptoms and the adherence to nasal continuous positive airway pressure (nCPAP) during the first 3-month nCPAP therapy among newly diagnosed patients with obstructive sleep apnea/hypopnea syndrome (OSAS) and to identify the effect of adherence on the changes in day- and nighttime symptoms during the first 3 months.Methods: Newly diagnosed OSAS patients were consecutively recruited from March to August 2013. Baseline clinical information and measures of the Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Zung’s Self-Rating Depression Scale (SDS) and the Pittsburgh Sleep Quality Index (PSQI) at baseline and the end of 3rd, 6th, 9th and 12th week of therapy were collected. Twelve weeks’ adherence was calculated as the average of each 3-week period. Mixed model was used to explore the effect of adherence to nCPAP therapy on ESS, FSS, SDS and PSQI in each 3-week phase.Results: Seventy-six patients completed the 12-week follow-up. The mixed-effects models showed that under the control of therapy phase adherence in the range of <4 hours per night, using nCPAP could independently improve daytime sleepiness, in terms of ESS (coefficient, [95% confidence interval] unit; –4.49 [–5.62, –3.36]). Adherence at 4–6 hours per night could independently improve all variables of day- and nighttime symptoms included in this study, namely ESS –6.69 (–7.40, –5.99), FSS –6.02 (–7.14, –4.91), SDS –2.40 (–2.95, –1.85) and PSQI –0.20 (–0.52, –0.12). Further improvement in symptoms could be achieved at ≥6 hours per night using nCPAP, which was ESS –8.35 (–9.26, –7.44), FSS –10.30 (–11.78, –8.83), SDS –4.42 (–5.15, –3.68) and PSQI –0.40 (–0.82, –0.02). The interaction between adherence level and therapy phase was not significant in day- and nighttime symptoms.Conclusion: The effect of adherence on the above-mentioned symptoms is stable through the first 3 months. Under the control of therapy phase, the nCPAP therapy effectively improves day- and nighttime symptoms with ≥4 hours adherence, and the patients can achieve a further improvement with ≥6 hours adherence. Keywords: OSAS, nCPAP, Epworth Sleepiness Scale, Fatigue Severity Scale , Zung’s Self-Rating Depression Scale, the Pittsburgh Sleep Quality Index
first_indexed 2024-04-12T17:07:36Z
format Article
id doaj.art-aedf74a40e1a46d18a4685983a8081eb
institution Directory Open Access Journal
issn 1177-889X
language English
last_indexed 2024-04-12T17:07:36Z
publishDate 2017-04-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj.art-aedf74a40e1a46d18a4685983a8081eb2022-12-22T03:23:53ZengDove Medical PressPatient Preference and Adherence1177-889X2017-04-01Volume 1176977932361Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapyWang YAi LLuo JLi RChai YHe XCao YLi YYeying Wang,1,2 Li Ai,1 Jiahong Luo,2 Ran Li,1 Yanlin Chai,1 Xiaojie He,1 Yu Cao,1 Yongxia Li1 1Department of Respiratory Medicine, The Second Affiliated Hospital of Kunming Medical University, 2Department of Epidemiology and Biostatistics, School of Public Health, Kunming Medical University, Chenggong New City, Kunming, Yunnan Province, People’s Republic of China Objectives: The aims of this study were to describe changes in day- and nighttime symptoms and the adherence to nasal continuous positive airway pressure (nCPAP) during the first 3-month nCPAP therapy among newly diagnosed patients with obstructive sleep apnea/hypopnea syndrome (OSAS) and to identify the effect of adherence on the changes in day- and nighttime symptoms during the first 3 months.Methods: Newly diagnosed OSAS patients were consecutively recruited from March to August 2013. Baseline clinical information and measures of the Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Zung’s Self-Rating Depression Scale (SDS) and the Pittsburgh Sleep Quality Index (PSQI) at baseline and the end of 3rd, 6th, 9th and 12th week of therapy were collected. Twelve weeks’ adherence was calculated as the average of each 3-week period. Mixed model was used to explore the effect of adherence to nCPAP therapy on ESS, FSS, SDS and PSQI in each 3-week phase.Results: Seventy-six patients completed the 12-week follow-up. The mixed-effects models showed that under the control of therapy phase adherence in the range of <4 hours per night, using nCPAP could independently improve daytime sleepiness, in terms of ESS (coefficient, [95% confidence interval] unit; –4.49 [–5.62, –3.36]). Adherence at 4–6 hours per night could independently improve all variables of day- and nighttime symptoms included in this study, namely ESS –6.69 (–7.40, –5.99), FSS –6.02 (–7.14, –4.91), SDS –2.40 (–2.95, –1.85) and PSQI –0.20 (–0.52, –0.12). Further improvement in symptoms could be achieved at ≥6 hours per night using nCPAP, which was ESS –8.35 (–9.26, –7.44), FSS –10.30 (–11.78, –8.83), SDS –4.42 (–5.15, –3.68) and PSQI –0.40 (–0.82, –0.02). The interaction between adherence level and therapy phase was not significant in day- and nighttime symptoms.Conclusion: The effect of adherence on the above-mentioned symptoms is stable through the first 3 months. Under the control of therapy phase, the nCPAP therapy effectively improves day- and nighttime symptoms with ≥4 hours adherence, and the patients can achieve a further improvement with ≥6 hours adherence. Keywords: OSAS, nCPAP, Epworth Sleepiness Scale, Fatigue Severity Scale , Zung’s Self-Rating Depression Scale, the Pittsburgh Sleep Quality Indexhttps://www.dovepress.com/effect-of--adherence-on-daytime-sleepiness-fatigue-depression-and-slee-peer-reviewed-article-PPAOSASnCPAPdaytime sleepinessfatiguedepressionsleep quality
spellingShingle Wang Y
Ai L
Luo J
Li R
Chai Y
He X
Cao Y
Li Y
Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
Patient Preference and Adherence
OSAS
nCPAP
daytime sleepiness
fatigue
depression
sleep quality
title Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
title_full Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
title_fullStr Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
title_full_unstemmed Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
title_short Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
title_sort effect of adherence on daytime sleepiness fatigue depression and sleep quality in the obstructive sleep apnea hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy
topic OSAS
nCPAP
daytime sleepiness
fatigue
depression
sleep quality
url https://www.dovepress.com/effect-of--adherence-on-daytime-sleepiness-fatigue-depression-and-slee-peer-reviewed-article-PPA
work_keys_str_mv AT wangy effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT ail effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT luoj effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT lir effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT chaiy effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT hex effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT caoy effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy
AT liy effectofadherenceondaytimesleepinessfatiguedepressionandsleepqualityintheobstructivesleepapneahypopneasyndromepatientsundertakingnasalcontinuouspositiveairwaypressuretherapy